This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Senate Bill 141
Relating to: third-party processing of applications for occupational therapists and occupational therapy assistants and granting rulemaking authority.
By Senators Stafsholt, Cabral-Guevara, Feyen and Wanggaard; cosponsored by Representatives Gustafson, Allen, Behnke, Binsfeld, Bodden, Dittrich, Green, Gundrum, Kitchens, Krug, Mursau, Rettinger, Rodriguez, Schmidt, Schraa, Schutt, Steffen, Tusler, Wichgers and O'Connor.
To the committee on Licensing, Constitution and Federalism.
Senate Bill 142
Relating to: waiver of fees for admission to state parks on Earth Day.
By Senators Quinn, Hesselbein, Roys, Spreitzer, Taylor, Larson and Cowles; cosponsored by Representatives Green, Joers, C. Anderson, Andraca, Armstrong, Bare, Behnke, Bodden, Conley, Considine, Kitchens, Moore Omokunde, Mursau, Ohnstad, Shankland, Sinicki, Snodgrass, Spiros, Steffen, Stubbs, Subeck and Tittl.
To the committee on Financial Institutions and Sporting Heritage.
Senate Bill 143
Relating to: the use of certain words and terms that refer to a physician.
By Senators Cabral-Guevara, Roys and Wanggaard; cosponsored by Representatives Magnafici, Dittrich, Murphy and Rozar.
To the committee on Health.
_____________
Petitions and Communications
Pursuant to Senate Rule 17 (5), Representative Bare added as a cosponsor of Senate Bill 110.
_____________
Referrals and Receipt of Committee Reports Concerning Proposed Administrative Rules
The joint committee for review of Administrative Rules reported and recommended:
Relating to nutritional counseling certification.
No action taken on March 22, 2023.
Relating to continuing medical education for physicians.
No action taken on March 17, 2023.
Relating to telehealth.
No action taken on March 17, 2023.
Relating to obsolete references to predetermination of criminal convictions in licensure applicants and apprenticeships.
No action taken on March 22, 2023.
Relating to telehealth.
No action taken on March 23, 2023.
Relating to reciprocal credentials for service members, former service members, and their spouses.
No action taken on March 15, 2023.
Relating to name and address change, floor design, procedures for disciplinary proceedings, superseded references, and technical correction.
No action taken on March 17, 2023.
Relating to requirements for class III permits for anesthesia.
No action taken on March 17, 2023.
Relating to home inspections and home inspector education.
No action taken on March 22, 2023.
Relating to notaries public and notarial acts.
No action taken on March 23, 2023.
Relating to scheduling Crotonyl Fentanyl.
No action taken on March 16, 2023.
Relating to scheduling Remimazolam.
No action taken on March 16, 2023.
Relating to radiation protection requirements for radiation-producing machines and radioactive materials.
No action taken on March 17, 2023.
Relating to scheduling Brorphine.
No action taken on March 16, 2023.
Relating to licensure and professional conduct.
No action taken on March 17, 2023.
Relating to service fund for people who are deaf, deafblind or hard of hearing.
No action taken on March 17, 2023.
Relating to use of the Nationwide Multistate Licensing System and Registry by applicants for, and holders of, licenses under s. 138.14 (payday lenders), ch. 217 (sellers of checks), ch. 218, subch. I (sales finance companies), and s. 218.02 (adjustment service companies) of the Wisconsin Statutes.
No action taken on March 23, 2023.
Relating to care fund income.
No action taken on March 15, 2023.
Relating to long-term care services and Medical Assistance fair hearing process.
No action taken on March 17, 2023.
Relating to licensure requirements.
No action taken on March 16, 2023.
Relating to continuing education.
No action taken on March 16, 2023.
Relating to scheduling Serdexmethylphenidate.
No action taken on March 16, 2023.
Relating to scheduling ten (10) fentanyl related substances.
No action taken on March 16, 2023.
Relating to scheduling Alfaxalone.
Loading...
Loading...